Publications

  1. Virata MC, Samanamud J, Slocum CC, Kandoi S, Nguyen P, Savani MR, Shi DD, Sharma S, Hiya S, Maldonado-Diaz C, Clare K, Yokoda RT, Vij M, Mir E, Nishikawa Y, Umphlett M, Yong RL, Bederson JB, Silva-Hurtado TJ, Brem S, Hambardzumyan D, Snuderl M, Viapiano MS, Abdullah KG, McBrayer SK, Hatanpaa KJ, Walker JM, Tsankova NM, Richardson TE. Expanding the molecular grading criteria in IDH-mutant astrocytoma. Neuro Oncol. 2026 Mar 28 [Epub ahead of print]
    View PubMed
  2. Welch RL, Fluss RS, Yokoda RT, Himes BT. Primary sporadic intracranial DICER1 mutant sarcoma with SSTR2 positivity in an adult patient mimicking anaplastic meningioma. J Neuropathol Exp Neurol. 2026 Feb 1; 85 (2):198-202
    View PubMed
  3. Nguyen P, Yokoda RT, Hossain Q, Bederson JB, Richardson TE. Solitary fibrous tumor-meningioma collision tumor with 18 years of follow-up. J Neuropathol Exp Neurol. 2025 Oct 1; 84 (10):950-953
    View PubMed
  4. Hiya S, Maldonado-Diaz C, Rohde SK, Gonzales MM, Canbeldek L, Kulumani Mahadevan LS, Yokoda RT, Sullivan AC, Parker AS, White CL 3rd, Daoud EV, Flores-Almazan V, Crary JF, Farrell K, Walker JM, Richardson TE. Unraveling the clinical-pathological correlations of subjects with isolated and mixed neurodegenerative processes in the National Alzheimer's Coordinating Center dataset. J Neuropathol Exp Neurol. 2025 Feb 21; 84 (3):177-194
    View PubMed
  5. Maldonado-Diaz C, Hiya S, Yokoda RT, Farrell K, Marx GA, Kauffman J, Daoud EV, Gonzales MM, Parker AS, Canbeldek L, Kulumani Mahadevan LS, Crary JF, White CL 3rd, Walker JM, Richardson TE. Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies. Acta Neuropathol. 2024 Mar 23; 147 (1):58
    View PubMed
  6. Walker JM, Orr ME, Orr TC, Thorn EL, Christie TD, Yokoda RT, Vij M, Ehrenberg AJ, Marx GA, McKenzie AT, Kauffman J, Selmanovic E, Wisniewski T, Drummond E, White CL 3rd, Crary JF, Farrell K, Kautz TF, Daoud EV, Richardson TE. Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy. Alzheimers Dement. 2024 Feb; 20 (2):783-797 Epub 2023 Sept 30
    View PubMed
  7. Yokoda RT, Cobb WS, Yong RL, Crary JF, Viapiano MS, Walker JM, Umphlett M, Tsankova NM, Richardson TE. CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytoma. J Neuropathol Exp Neurol. 2023 Sep 20; 82 (10):845-852
    View PubMed
  8. Vij M, Cho BB, Yokoda RT, Rashidipour O, Umphlett M, Richardson TE, Tsankova NM. P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas. Acta Neuropathol Commun. 2023 May 3; 11 (1):73 Epub 2023 May 03
    View PubMed
  9. Anderson C, Sriram A, Funari A, Hsu K, Yokoda R, Pecorari I, Flaquer I, Akbar N, Colley P, Basson G, Moskowitz HS, Agarwal V. High-Grade Ectopic Pituitary Adenoma within the Cerebellopontine Angle: A Case Report. J Neurol Surg Rep. 2023 Apr; 84 (2):e51-e58 Epub 2023 Apr 21
    View PubMed
  10. Vij M, Yokoda RT, Rashidipour O, Tran I, Vasudevaraja V, Snuderl M, Yong RL, Cobb WS, Umphlett M, Walker JM, Tsankova NM, Richardson TE. The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomas. Neurooncol Adv. 2023 Jan-Dec; 5 (1):vdad069 Epub 2023 May 29
    View PubMed
  11. Richardson TE, Yokoda RT, Rashidipour O, Vij M, Snuderl M, Brem S, Hatanpaa KJ, McBrayer SK, Abdullah KG, Umphlett M, Walker JM, Tsankova NM. Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma. Neurooncol Adv. 2023 Jan-Dec; 5 (1):vdad085 Epub 2023 July 12
    View PubMed
  12. Yokoda RT, Rodriguez EA. Review: Pathogenesis of cholestatic liver diseases. World J Hepatol. 2020 Aug 27; 12 (8):423-435
    View PubMed
  13. Szymczak WA, Goldstein DY, Orner EP, Fecher RA, Yokoda RT, Skalina KA, Narlieva M, Gendlina I, Fox AS. Utility of Stool PCR for the Diagnosis of COVID-19: Comparison of Two Commercial Platforms. J Clin Microbiol. 2020 Aug 24; 58 (9)
    View PubMed
  14. Yokoda RT, Carey EJ. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Am J Gastroenterol. 2019 Oct; 114 (10):1593-1605
    View PubMed
  15. Rodriguez EA, Teixeira Yokoda R, Payton DE, Pai R, Byrne TJ. Acute Hepatitis Secondary to the Use of Ilex paraguariensis (Mate Tea): A Case Report and Review of Literature. Case Reports Hepatol. 2019; 2019:8459205 Epub 2019 Oct 13
    View PubMed
  16. DeLeon TT, Salomao MA, Aqel BA, Sonbol MB, Yokoda RT, Ali AH, Moss AA, Mathur AK, Chascsa DM, Rakela J, Bryce AH, Borad MJ. Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience. J Gastrointest Oncol. 2018 Dec; 9 (6):1054-1062
    View PubMed
  17. DeLeon TT, Zhou Y, Nagalo BM, Yokoda RT, Ahn DH, Ramanathan RK, Salomao MA, Aqel BA, Mahipal A, Bekaii-Saab TS, Borad MJ. Novel immunotherapy strategies for hepatobiliary cancers. Immunotherapy. 2018 Sep; 10 (12):1077-1091
    View PubMed
  18. Yokoda RT, Nagalo BM, Borad MJ. Oncolytic Adenoviruses in Gastrointestinal Cancers. Biomedicines. 2018 Mar 11; 6 (1)
    View PubMed
  19. Sanou M, Ouedraogo A, Konkobo A, Compaore T, Nagalo B, Yokoda R, Borad MJ, Sanou I, Sangare L, Simpore J. Treatment and Management of Bacterial Purulent Acute Otitis at the Bogodogo District Community Hospital, Burkina Faso, West Africa. Arch Clin Microbiol. 2018; 9(1):75.
  20. Yokoda R, Nagalo BM, Vernon B, Oklu R, Albadawi H, DeLeon TT, Zhou Y, Egan JB, Duda DG, Borad MJ. Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect. Oncolytic Virother. 2017; 6:39-49 Epub 2017 Nov 08
    View PubMed
  21. Yokoda R, Nagalo BM, Arora M, Egan JB, Bogenberger JM, DeLeon TT, Zhou Y, Ahn DH, Borad MJ. Oncolytic virotherapy in upper gastrointestinal tract cancers. Oncolytic Virother. 2017; 7:13-24 Epub 2018 Mar 23
    View PubMed